The funding comes from Eight Roads Ventures (a global proprietary investment firm backed by Fidelity), Nufarm, Endeavor8, and Akroyd LLC. This raise, which follows Enko's initial close of $70 million in July 2022, brings the company's overall capital raised to date to $150 million. Enko will use the new funds to advance the company's product pipeline of novel crop protection chemistries and provide critical solutions for large scale global food security challenges.

Enko Chem designs safe and sustainable solutions to farmers' biggest crop threats today, from pest resistance to new diseases by applying the latest drug discovery and development approaches from pharma to agriculture.